Form 4: Ingevity Corp Executive Richard Allen White JR Reports Changes in Beneficial Ownership

Richard Allen White JR, SVP and President of Performance Chemicals at Ingevity Corp, reports transactions involving common stock and restricted stock units (RSUs) on February 28, 2024.

Summary

• On February 28, 2024, Richard Allen White JR, an officer at Ingevity Corp, engaged in transactions involving the company's common stock.
• A total of 171 shares were withheld to cover tax obligations related to the vesting of 2022 restricted stock units (RSUs) at a price of $45.27.
• An additional 362 shares were withheld to cover tax obligations related to the vesting of 2023 RSUs at a price of $45.27.
• White was granted 6,097 RSUs and 2,139 RSUs, which will vest in three equal installments on February 28 of 2025, 2026, and 2027.
• Following these transactions, White directly owns 14,691 shares of Ingevity Corp common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The grant of RSUs to a key executive could be seen as a positive sign, aligning the executive's interests with the long-term performance of the company.

Future Outlook

The granted RSUs will vest in three equal installments on February 28, 2025, 2026, and 2027.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• Shareholders are informed about insider transactions, which can provide insights into management's perspective on the company's value.

Key Dates